Drugmaker sues competitor for alleged sham litigation

Nihal Krishan

10 August 2017

Credit: Alnylam Pharmaceuticals

Biopharmaceutical company Dicerna Pharmaceuticals has sued Alnylam Pharmaceuticals for allegedly using sham litigation and public announcements against Dicerna to illegally obtain market dominance.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Nihal Krishan

View full biography

Author

[email protected]

Unlock unlimited access to all Global Competition Review content